ATF7_HUMAN - dbPTM
ATF7_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID ATF7_HUMAN
UniProt AC P17544
Protein Name Cyclic AMP-dependent transcription factor ATF-7
Gene Name ATF7
Organism Homo sapiens (Human).
Sequence Length 494
Subcellular Localization Nucleus . Nucleus, nucleoplasm . Mainly nucleoplasmic. Restricted distribution to the perinuculear region. The sumoylated form locates to the nuclear periphery.
Isoform 5: Cytoplasm .
Protein Description Plays important functions in early cell signaling. Binds the cAMP response element (CRE) (consensus: 5'-GTGACGT[AG][AG]-3'), a sequence present in many viral and cellular promoters. Activator of the NF-ELAM1/delta-A site of the E-selectin promoter. Has no intrinsic transcriptional activity, but activates transcription on formation of JUN or FOS heterodimers. Also can bind TRE promoter sequences when heterodimerized with members of the JUN family.; Isoform 4 acts as a dominant repressor of the E-selectin/NF-ELAM1/delta-A promoter.; Isoform 5 acts as a negative regulator, inhibiting both ATF2 and ATF7 transcriptional activities. It may exert these effects by sequestrating in the cytoplasm the Thr-53 phosphorylating kinase, preventing activation..
Protein Sequence MGDDRPFVCNAPGCGQRFTNEDHLAVHKHKHEMTLKFGPARTDSVIIADQTPTPTRFLKNCEEVGLFNELASSFEHEFKKAADEDEKKARSRTVAKKLVAAAGPLDMSLPSTPDIKIKEEEPVEVDSSPPDSPASSPCSPPLKEKEVTPKPVLISTPTPTIVRPGSLPLHLGYDPLHPTLPSPTSVITQAPPSNRQMGSPTGSLPLVMHLANGQTMPVLPGPPVQMPSVISLARPVSMVPNIPGIPGPPVNSSGSISPSGHPIPSEAKMRLKATLTHQVSSINGGCGMVVGTASTMVTARPEQSQILIQHPDAPSPAQPQVSPAQPTPSTGGRRRRTVDEDPDERRQRFLERNRAAASRCRQKRKLWVSSLEKKAEELTSQNIQLSNEVTLLRNEVAQLKQLLLAHKDCPVTALQKKTQGYLESPKESSEPTGSPAPVIQHSSATAPSNGLSVRSAAEAVATSVLTQMASQRTELSMPIQSHVIMTPQSQSAGR
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
34PhosphorylationHKHKHEMTLKFGPAR
EECCCEEEEEECCCC
24.6622304920
42PhosphorylationLKFGPARTDSVIIAD
EEECCCCCCCEEEEC
34.4328176443
44PhosphorylationFGPARTDSVIIADQT
ECCCCCCCEEEECCC
18.0123401153
51PhosphorylationSVIIADQTPTPTRFL
CEEEECCCCCCCHHH
29.6729255136
53PhosphorylationIIADQTPTPTRFLKN
EEECCCCCCCHHHHC
40.4529255136
55PhosphorylationADQTPTPTRFLKNCE
ECCCCCCCHHHHCHH
36.2129255136
59UbiquitinationPTPTRFLKNCEEVGL
CCCCHHHHCHHHCCH
57.7629967540
72PhosphorylationGLFNELASSFEHEFK
CHHHHHHHHHHHHHH
48.4625849741
73PhosphorylationLFNELASSFEHEFKK
HHHHHHHHHHHHHHH
29.1025849741
79UbiquitinationSSFEHEFKKAADEDE
HHHHHHHHHHCCHHH
38.2229967540
91PhosphorylationEDEKKARSRTVAKKL
HHHHHHHHHHHHHHH
36.8424702127
93PhosphorylationEKKARSRTVAKKLVA
HHHHHHHHHHHHHHH
26.5124702127
100 (in isoform 2)Phosphorylation-11.3029507054
101PhosphorylationVAKKLVAAAGPLDMS
HHHHHHHHHCCCCCC
12.8918950637
101 (in isoform 2)Phosphorylation-12.8929743597
108PhosphorylationAAGPLDMSLPSTPDI
HHCCCCCCCCCCCCC
36.4729255136
111PhosphorylationPLDMSLPSTPDIKIK
CCCCCCCCCCCCCCC
58.8430266825
112PhosphorylationLDMSLPSTPDIKIKE
CCCCCCCCCCCCCCC
24.0429255136
118SumoylationSTPDIKIKEEEPVEV
CCCCCCCCCCCCCCC
54.8117264123
118SumoylationSTPDIKIKEEEPVEV
CCCCCCCCCCCCCCC
54.81-
121 (in isoform 4)Phosphorylation-56.5929116813
124 (in isoform 4)Phosphorylation-51.8529116813
125 (in isoform 4)Phosphorylation-9.8429116813
127PhosphorylationEEPVEVDSSPPDSPA
CCCCCCCCCCCCCCC
50.3425159151
128PhosphorylationEPVEVDSSPPDSPAS
CCCCCCCCCCCCCCC
35.6725159151
132PhosphorylationVDSSPPDSPASSPCS
CCCCCCCCCCCCCCC
28.3025159151
135PhosphorylationSPPDSPASSPCSPPL
CCCCCCCCCCCCCCC
37.8925159151
136PhosphorylationPPDSPASSPCSPPLK
CCCCCCCCCCCCCCC
31.8425159151
139PhosphorylationSPASSPCSPPLKEKE
CCCCCCCCCCCCCCC
32.7025022875
148PhosphorylationPLKEKEVTPKPVLIS
CCCCCCCCCCCEEEE
27.0420068231
155PhosphorylationTPKPVLISTPTPTIV
CCCCEEEECCCCCEE
24.9529978859
156PhosphorylationPKPVLISTPTPTIVR
CCCEEEECCCCCEEC
24.9622496350
158PhosphorylationPVLISTPTPTIVRPG
CEEEECCCCCEECCC
32.9020068231
160PhosphorylationLISTPTPTIVRPGSL
EEECCCCCEECCCCC
34.2820068231
166PhosphorylationPTIVRPGSLPLHLGY
CCEECCCCCCCCCCC
29.5128464451
173PhosphorylationSLPLHLGYDPLHPTL
CCCCCCCCCCCCCCC
22.2828122231
179PhosphorylationGYDPLHPTLPSPTSV
CCCCCCCCCCCCCCE
40.3228464451
182PhosphorylationPLHPTLPSPTSVITQ
CCCCCCCCCCCEEEE
43.8725849741
184PhosphorylationHPTLPSPTSVITQAP
CCCCCCCCCEEEECC
39.7125850435
185PhosphorylationPTLPSPTSVITQAPP
CCCCCCCCEEEECCC
18.2028464451
188PhosphorylationPSPTSVITQAPPSNR
CCCCCEEEECCCCCC
19.2725850435
193PhosphorylationVITQAPPSNRQMGSP
EEEECCCCCCCCCCC
43.5225850435
199PhosphorylationPSNRQMGSPTGSLPL
CCCCCCCCCCCCCCE
17.5928348404
201PhosphorylationNRQMGSPTGSLPLVM
CCCCCCCCCCCCEEE
40.8928348404
203PhosphorylationQMGSPTGSLPLVMHL
CCCCCCCCCCEEEEE
29.3228348404
213 (in isoform 4)Ubiquitination-20.8021890473
227PhosphorylationPGPPVQMPSVISLAR
CCCCCCCCCCHHCCC
14.3532142685
237PhosphorylationISLARPVSMVPNIPG
HHCCCCCCCCCCCCC
19.4226074081
248PhosphorylationNIPGIPGPPVNSSGS
CCCCCCCCCCCCCCC
25.0632142685
252PhosphorylationIPGPPVNSSGSISPS
CCCCCCCCCCCCCCC
35.9926657352
253PhosphorylationPGPPVNSSGSISPSG
CCCCCCCCCCCCCCC
31.2129255136
255PhosphorylationPPVNSSGSISPSGHP
CCCCCCCCCCCCCCC
23.1126657352
257PhosphorylationVNSSGSISPSGHPIP
CCCCCCCCCCCCCCC
18.0829255136
259PhosphorylationSSGSISPSGHPIPSE
CCCCCCCCCCCCCCH
42.8329255136
265PhosphorylationPSGHPIPSEAKMRLK
CCCCCCCCHHHHHHH
51.4029255136
304PhosphorylationVTARPEQSQILIQHP
EEECHHHCCEEEECC
19.9529255136
315PhosphorylationIQHPDAPSPAQPQVS
EECCCCCCCCCCCCC
34.2929255136
322PhosphorylationSPAQPQVSPAQPTPS
CCCCCCCCCCCCCCC
14.8529255136
327PhosphorylationQVSPAQPTPSTGGRR
CCCCCCCCCCCCCCC
20.1425850435
330PhosphorylationPAQPTPSTGGRRRRT
CCCCCCCCCCCCCCC
44.87-
334UbiquitinationTPSTGGRRRRTVDED
CCCCCCCCCCCCCCC
35.3932015554
337PhosphorylationTGGRRRRTVDEDPDE
CCCCCCCCCCCCHHH
30.4229255136
342UbiquitinationRRTVDEDPDERRQRF
CCCCCCCHHHHHHHH
43.2329967540
358PhosphorylationERNRAAASRCRQKRK
HHHHHHHHHHHHHHH
27.4722817900
363UbiquitinationAASRCRQKRKLWVSS
HHHHHHHHHHHHHHH
31.9529967540
368UbiquitinationRQKRKLWVSSLEKKA
HHHHHHHHHHHHHHH
3.9521890473
368 (in isoform 2)Ubiquitination-3.9521890473
368PhosphorylationRQKRKLWVSSLEKKA
HHHHHHHHHHHHHHH
3.9532142685
379 (in isoform 3)Ubiquitination-31.3921890473
389UbiquitinationNIQLSNEVTLLRNEV
CCCCHHHHHHHHHHH
5.5221890473
389UbiquitinationNIQLSNEVTLLRNEV
CCCCHHHHHHHHHHH
5.5221890473
400 (in isoform 1)Ubiquitination-27.1621890473
400UbiquitinationRNEVAQLKQLLLAHK
HHHHHHHHHHHHHCC
27.1632015554
402PhosphorylationEVAQLKQLLLAHKDC
HHHHHHHHHHHCCCC
3.9632142685
413PhosphorylationHKDCPVTALQKKTQG
CCCCCCHHHHHHHCC
14.2924275569
418PhosphorylationVTALQKKTQGYLESP
CHHHHHHHCCCCCCC
33.9718669648
421PhosphorylationLQKKTQGYLESPKES
HHHHHCCCCCCCCCC
9.4730576142
423PhosphorylationKKTQGYLESPKESSE
HHHCCCCCCCCCCCC
57.4123186163
424PhosphorylationKTQGYLESPKESSEP
HHCCCCCCCCCCCCC
38.3825159151
428PhosphorylationYLESPKESSEPTGSP
CCCCCCCCCCCCCCC
46.2430266825
429PhosphorylationLESPKESSEPTGSPA
CCCCCCCCCCCCCCC
49.0030266825
432PhosphorylationPKESSEPTGSPAPVI
CCCCCCCCCCCCCEE
46.3623401153
434PhosphorylationESSEPTGSPAPVIQH
CCCCCCCCCCCEEEC
21.9929255136
442PhosphorylationPAPVIQHSSATAPSN
CCCEEECCCCCCCCC
12.8023403867
442 (in isoform 1)O-linked_Glycosylation-12.8030059200
443PhosphorylationAPVIQHSSATAPSNG
CCEEECCCCCCCCCC
27.7523403867
445PhosphorylationVIQHSSATAPSNGLS
EEECCCCCCCCCCCC
40.8423403867
448PhosphorylationHSSATAPSNGLSVRS
CCCCCCCCCCCCHHH
40.8617081983
452PhosphorylationTAPSNGLSVRSAAEA
CCCCCCCCHHHHHHH
19.5117081983
455 (in isoform 1)O-linked_Glycosylation-29.6730059200
455O-linked_GlycosylationSNGLSVRSAAEAVAT
CCCCCHHHHHHHHHH
29.6730059200
462O-linked_GlycosylationSAAEAVATSVLTQMA
HHHHHHHHHHHHHHH
16.8730059200
463 (in isoform 1)O-linked_Glycosylation-12.8530059200
470PhosphorylationSVLTQMASQRTELSM
HHHHHHHHCCCCCCC
18.1726714015
473PhosphorylationTQMASQRTELSMPIQ
HHHHHCCCCCCCCCC
33.3727251275
476PhosphorylationASQRTELSMPIQSHV
HHCCCCCCCCCCCEE
19.1127251275
481PhosphorylationELSMPIQSHVIMTPQ
CCCCCCCCEEEECCC
22.0527251275
486PhosphorylationIQSHVIMTPQSQSAG
CCCEEEECCCHHCCC
13.6725159151
489PhosphorylationHVIMTPQSQSAGR--
EEEECCCHHCCCC--
27.5727251275
491PhosphorylationIMTPQSQSAGR----
EECCCHHCCCC----
37.6327251275

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
51TPhosphorylationKinaseP38BQ15759
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
51TPhosphorylation

10376527
53TPhosphorylation

10376527

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of ATF7_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
TAF12_HUMANTAF12physical
15735663
TAF4_HUMANTAF4physical
15735663
CREB1_HUMANCREB1physical
22939629
MK08_HUMANMAPK8physical
11566021
OCAD1_HUMANOCIAD1physical
20195357
RMP_HUMANURI1physical
20195357
TAOK3_HUMANTAOK3physical
20195357
MITD1_HUMANMITD1physical
20195357
KASH5_HUMANCCDC155physical
25416956
FAM9B_HUMANFAM9Bphysical
25416956
TM239_HUMANTMEM239physical
25416956
MBD3_HUMANMBD3physical
21516116

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
DB00852Pseudoephedrine
Regulatory Network of ATF7_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-42; THR-51; THR-53;SER-108 AND THR-112, AND MASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-51; THR-53; THR-55 ANDSER-424, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-51; THR-53; SER-108 ANDTHR-112, AND MASS SPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-108 AND THR-112, ANDMASS SPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-51; THR-53; SER-111;THR-112; SER-127; SER-128; SER-132; SER-135; SER-136 AND SER-139, ANDMASS SPECTROMETRY.
"p38beta2-mediated phosphorylation and sumoylation of ATF7 aremutually exclusive.";
Camuzeaux B., Diring J., Hamard P.J., Oulad-Abdelghani M., Donzeau M.,Vigneron M., Kedinger C., Chatton B.;
J. Mol. Biol. 384:980-991(2008).
Cited for: PHOSPHORYLATION AT THR-51; THR-53 AND THR-112, SUMOYLATION AT LYS-118,FUNCTION, AND MUTAGENESIS OF THR-51; THR-53; THR-112 AND LYS-118.

TOP